Phio Pharmaceuticals (DE:44R3)

Phio Pharmaceuticals Financial Statements


Phio Pharmaceuticals Financial Overview

Phio Pharmaceuticals's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Phio Pharmaceuticals is scheduled to report earnings on March 30, 2023, and the estimated EPS forecast is €-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -3.57M$ -2.52M$ -2.64M$ -3.45M$ -3.74M
EBITDA$ -3.56M$ -2.50M$ -2.62M$ -3.43M$ -3.72M
Net Income Common Stockholders$ -3.58M$ -2.53M$ -2.64M$ -3.45M$ -3.74M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 14.48M$ 18.02M$ 20.46M$ 24.06M$ 26.53M
Total Assets$ 15.79M$ 20.14M$ 22.16M$ 25.17M$ 27.94M
Total Debt$ 202.00K$ 234.00K$ 265.00K$ 295.00K$ 314.00K
Net Debt$ -14.28M$ -17.79M$ -20.19M$ -23.76M$ -26.21M
Total Liabilities$ 2.26M$ 3.14M$ 2.71M$ 3.24M$ 2.70M
Stockholders Equity$ 13.53M$ 17.00M$ 19.45M$ 21.93M$ 25.25M
Cash Flow
Free Cash Flow$ -3.53M$ -2.44M$ -3.57M$ -2.47M$ -3.13M
Operating Cash Flow$ -3.53M$ -2.43M$ -3.47M$ -2.47M$ -3.10M
Investing Cash Flow$ -7.00K$ -10.00K$ -104.00K$ 0.00$ -30.00K
Financing Cash Flow$ -3.00K$ 0.00$ -25.00K$ -1.00K$ 233.00K
Currency in USD

Phio Pharmaceuticals Earnings and Revenue History

Phio Pharmaceuticals Debt to Assets

Phio Pharmaceuticals Cash Flow

Phio Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis